It was a very CIRMy news week on both the clinical trial and discovery research fronts. Here are some the highlights: Stanford cancer-fighting spinout to Genentech: 'Don't eat me' – San Francisco Business Times Ron Leuty, of the San Francisco Business Times, reported this week on not one, but two news releases from CIRM grantee … Continue reading Stem Cell RoundUp: CIRM Clinical Trial Updates & Mapping Human Brain
CIRM News
UCLA scientists make sensory nerves from human stem cells for the first time
Being able to tell the difference between hot and cold or feeling the embrace of a loved one are experiences that many of us take for granted in our daily lives. But paralyzed patients who have lost their sense of touch don’t have this luxury. Sensory nerves are cells in the spinal cord that send … Continue reading UCLA scientists make sensory nerves from human stem cells for the first time
How CIRM funding creates additional financial support for stem cell research in California
CIRM’s 2017 Annual Report will be going live online very soon. In anticipation of that we are highlighting some of the key elements from the report here on the Stem Cellar. CIRM funds stem cell research. We all know that. What you may not know is that CIRM funds also help bring in additional funding … Continue reading How CIRM funding creates additional financial support for stem cell research in California
How Tom Howing turned to stem cells to battle back against a deadly cancer
As we enter the new year, CIRM’s 2017 Annual Report will be posted in less than two weeks! Here’s one of the people we are profiling in the report, a patient who took part in a CIRM-funded clinical trial. In March of 2015, Tom Howing was diagnosed with stage 4 cancer. Over the next 18 … Continue reading How Tom Howing turned to stem cells to battle back against a deadly cancer
Accelerating stem cell treatments to patients in 2017
As we enter the new year, CIRM’s 2017 Annual Report will be posted in a few short weeks! Here’s a sneak peek at CIRM’s progress in clinical trials. At the start of 2017, we set a goal of finding and funding 12 new, high quality clinical trials. We easily beat that goal, funding 16, in … Continue reading Accelerating stem cell treatments to patients in 2017
The 10 Most Popular Stem Cellar Stories of 2017
As the New Year fast approaches, it’s time for us to reflect on our accomplishments these past 12 months. 2017 was an exciting and successful year for California’s Stem Cell Agency. We welcomed Dr. Maria Millan as the new President and CEO of CIRM. We also funded 16 new clinical trials and added two new … Continue reading The 10 Most Popular Stem Cellar Stories of 2017
Making beating heart cells from stem cells just got easier
Here’s a heartwarming story for the holidays. Scientists from the Salk Institute in La Jolla, California have figured out a simple, easy way to make beating heart cells from human stem cells that will aid research and therapy development for heart disease. Their study, which received funding support from CIRM, was published last week in … Continue reading Making beating heart cells from stem cells just got easier
Harnessing the body’s immune system to tackle cancer
Often on the Stem Cellar we write about work that is in a clinical trial. But getting research to that stage takes years and years of dedicated work. Over the next few months, we are profiling some of the scientists we fund who are doing Discovery (early stage) and Translational (pre-clinical) research, to highlight the … Continue reading Harnessing the body’s immune system to tackle cancer
CHLA study explains how stem cells slow progression of kidney disorder
Not all stem cell-based therapies act by replacing diseased or damaged cells. Many treatments in clinical development rely on the injected stem cells releasing proteins which trigger the slow down or even reversal of damage caused by disease or injury. A new CIRM-funded study that’s developing a stem cell therapy for a rare kidney disease … Continue reading CHLA study explains how stem cells slow progression of kidney disorder
Budgeting for the future of the stem cell agency
Budgets are very rarely exciting things; but they are important. For example, it’s useful for a family to know when they go shopping exactly how much money they have so they know how much they can afford to spend. Stem cell agencies face the same constraints; you can’t spend more than you have. Last week … Continue reading Budgeting for the future of the stem cell agency